To Be Discontinued Tablet Other
Pilocarpine Hydrochloride Ta · 357 days since initial FDA posting
Brand: PILOCARPINE HYDROCHLORIDE
FDA lists Pilocarpine Hydrochloride Ta as To Be Discontinued (Actavis Pharma, Inc.).
No availability text on this FDA row.
Pilocarpine Hydrochloride Tablet: To Be Discontinued
FDA availability text is not recorded on this row. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Pilocarpine Hydrochloride Tablet
- Manufacturer
- Actavis Pharma, Inc.
- Dosage Form
- Tablet
- Presentation
- Salagen, Tablet, 7.5 mg (NDC 0228-2837-11)
- Package NDC
- 0228-2837-11
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Sep 19, 2025
- Last Updated
- Sep 19, 2025
- Therapeutic Category
- Other
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug.
Nearby, Other Pilocarpine Shortage Records
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.